Long-Term Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Stents in Patients With Acute Myocardial Infarction: Four-Year Observational Study |
Min, Gye-Sik
(Department of Cardiology, Chungnam National University School of Medicine)
Lee, Jae-Hwan (Department of Cardiology, Chungnam National University School of Medicine) Park, Jae-Ho (Department of Cardiology, Chungnam National University School of Medicine) Choi, Ung-Lim (Department of Cardiology, Chungnam National University School of Medicine) Lee, Young-Dal (Department of Cardiology, Chungnam National University School of Medicine) Seong, Seok-Woo (Department of Cardiology, Chungnam National University School of Medicine) Jin, Seon-Ah (Department of Cardiology, Chungnam National University School of Medicine) Park, Soo-Jin (Department of Cardiology, Chungnam National University School of Medicine) Kim, Jun-Hyeong (Department of Cardiology, Chungnam National University School of Medicine) Park, Jae-Hyeong (Department of Cardiology, Chungnam National University School of Medicine) Choi, Si-Wan (Department of Cardiology, Chungnam National University School of Medicine) Jeong, Jin-Ok (Department of Cardiology, Chungnam National University School of Medicine) Seong, In-Whan (Department of Cardiology, Chungnam National University School of Medicine) |
1 | Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23. DOI ScienceOn |
2 | Sabate M, Jimenez-Quevedo P, Angiolillo DJ, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (diabetes) trial. Circulation 2005;112:2175-83. DOI ScienceOn |
3 | Silber S, Colombo A, Banning AP, et al. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions. Circulation 2009;120:1498-504. DOI ScienceOn |
4 | Kastrati A, Dibra A, Eberle S, et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA 2005;294:819-25. DOI ScienceOn |
5 | Kastrati A, Dibra A, Spaulding C, et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 2007;28:2706-13. DOI ScienceOn |
6 | De Luca G, Stone GW, Suryapranata H, et al. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Int J Cardiol 2009;133:213-22. DOI ScienceOn |
7 | Hao PP, Chen YG, Wang XL, Zhang Y. Efficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarction: a meta-analysis of randomized controlled trials. Tex Heart Inst J 2010;37:516-24. |
8 | Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:588-636. DOI ScienceOn |
9 | Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51. DOI ScienceOn |
10 | Piscione F, Piccolo R, Cassese S, et al. Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis of randomised trials and an adjusted indirect comparison. EuroIntervention 2010;5:853-60. DOI ScienceOn |
11 | Lee JH, Kim HS, Lee SW, et al. Prospective randomized comparison of sirolimus- versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction: pROSIT trial. Catheter Cardiovasc Interv 2008;72:25-32. |
12 | Lee CW, Park DW, Lee SH, et al. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction. Am J Cardiol 2009;104:1370-6. DOI ScienceOn |
13 | Daemen J, Tanimoto S, García-García HM, et al. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SERCH Registries). Am J Cardiol 2007;99:1027-32. DOI ScienceOn |
14 | Bose R, Gupta G, Grayburn PA, Laible EA, Kang MJ, Choi JW. Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center. Am J Cardiol 2007;100:949-52. DOI ScienceOn |
![]() |